Prelude Therapeutics Inc
NASDAQ:PRLD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Prelude Therapeutics Inc
NASDAQ:PRLD
|
US |
|
E
|
Eneco Refresh Ltd
ASX:ERG
|
AU |
|
Marel hf
AEX:MAREL
|
IS |
|
Bank Raya Indonesia Tbk PT
IDX:AGRO
|
ID |
|
JetBlue Airways Corp
NASDAQ:JBLU
|
US |
|
Selaras Citra Nusantara Perkasa Tbk PT
IDX:SCNP
|
ID |
|
Dorman Products Inc
NASDAQ:DORM
|
US |
|
Scidev Ltd
ASX:SDV
|
AU |
|
Micropole SA
PAR:ALMIC
|
FR |
|
QuickFee Ltd
ASX:QFE
|
AU |
|
P
|
Petrolimex Installation No III JSC
VN:PEN
|
VN |
|
FAR Ltd
ASX:FAR
|
AU |
|
Kongsberg Automotive ASA
OSE:KOA
|
NO |
|
O
|
Osteonic Co Ltd
KOSDAQ:226400
|
KR |
|
M
|
MAS Real Estate Inc
JSE:MSP
|
IM |
Bankruptcy Probability
Prelude Therapeutics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Prelude Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Prelude Therapeutics Inc
NASDAQ:PRLD
|
217.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
362.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Prelude Therapeutics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Prelude Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
